Medicare’s second group of negotiated drug prices takes effect January 1, 2027. CMS says the group covers 15 Part D drugs, bringing the total to 25 when combined with the first ten whose prices began in 2026.
The official term is a maximum fair price. A negotiated program price should not be read as a promise that every patient will pay that number at the pharmacy. Your coverage, benefit stage and prescription details still matter.
Check the exact medicine
CMS publishes the selected drugs and their negotiated prices in an official fact sheet. Compare that list with the name, formulation and strength on your prescription rather than matching a broad condition such as diabetes or cancer. Ask your pharmacist how your plan will apply the change to your specific prescription.
The CMS fact sheet says Medicare prescription plans must include the selected drugs in their formularies. Coverage details and access requirements still deserve checking during your plan comparison.
Keep two changes separate
Drug-price negotiation and Part D’s annual out-of-pocket threshold are different features. One concerns prices for selected medicines; the other concerns qualifying annual spending under the drug benefit.
When comparing 2027 plans, save the estimated yearly medicine cost and pharmacy you entered. That record gives you something concrete to revisit if a quote changes. Continue taking prescribed medicine as directed and discuss treatment or cost concerns with the clinician and pharmacist who know your care.
